Finally, future studies should incorporate the distinct roles of different SOD isoforms (SOD1, SOD2, and SOD3) in colorectal cancer prognosis, as their specific contributions may influence biomarker development and clinical applications. This evidence concerns the gene SOD2 and colorectal cancer.